aclens.com - Acuvue Contact Lenses for Less    Shop Warby Parker Online   



Planned Spin-Off Will Allow Alcon to Better Focus on Growth Strategies, CEO Endicott Says

FORT WORTH, Texas—The “new” Alcon that emerges from a planned spin-off from Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session....


J&J Cites Pharmaceutical Segment for Driving a 10.6 Percent Increase in Second-Quarter Sales

NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational gro...


Alcon’s New CEO Endicott Says Eyecare Company Is Committed to Fort Worth

FORT WORTH, Texas—Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....


SynergEyes Appoints Bob Ferrigno as CEO; Prepares to Boost Specialty Business

CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27....


Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Custom Contact Lens Coating Technology

BRIDGEWATER, N.J.—Bausch + Lomb, a leading global eye health company, announced that it has entered into a worldwide licensing agreement with Tangible Science, LLC, a company whose mission is to create technologies that improve the contact lens wearing experience....


SynergEyes and Brien Holden Vision Institute Partner on Contact Lens Development

CARLSBAD, Calif.—SynergEyes, a leading hybrid specialty contact lens company, announced a new partnership with the Brien Holden Vision Institute,  the leading translational vision correction center which delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by Brien Holden Vision Institute, augmenting the SynergEyes presbyopic package by offering the latest designs on t...


Contact Lenses News:

Planned Spin-Off Will Allow Alcon to Better Focus on Growth Strategies, CEO Endicott Says

FORT WORTH, Texas—The “new” Alcon that emerges from a planned spin-off from Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session....


J&J Cites Pharmaceutical Segment for Driving a 10.6 Percent Increase in Second-Quarter Sales

NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational gro...


Alcon’s New CEO Endicott Says Eyecare Company Is Committed to Fort Worth

FORT WORTH, Texas—Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....


SynergEyes Appoints Bob Ferrigno as CEO; Prepares to Boost Specialty Business

CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27....


Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Custom Contact Lens Coating Technology

BRIDGEWATER, N.J.—Bausch + Lomb, a leading global eye health company, announced that it has entered into a worldwide licensing agreement with Tangible Science, LLC, a company whose mission is to create technologies that improve the contact lens wearing experience....


SynergEyes and Brien Holden Vision Institute Partner on Contact Lens Development

CARLSBAD, Calif.—SynergEyes, a leading hybrid specialty contact lens company, announced a new partnership with the Brien Holden Vision Institute,  the leading translational vision correction center which delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by Brien Holden Vision Institute, augmenting the SynergEyes presbyopic package by offering the latest designs on t...


SKU-V11-148 Focus Monthly Visitint from 1 800 get lens  sku

Focus Monthly Visitint - V11-148 by CIBA Vision

Item description: This Contact Lenses Monthly Disposable product is by CIBA Vision - Focus Monthly are soft contact lenses that offer the freedom of crisp, clear vision and enhanced comfort through frequent replacement.These lenses are also available in COLOR! Focus Monthly lenses are available in an array of beautiful colors.Click here to check out Focus Monthly SoftColors.... Learn More

Manufacturer: CIBA Vision

Keywords: Focus Monthly Visitint CIBA Vision Monthly Disposable

1-800-GET-LENS

Store: We provide customers with top brands like Bausch&Lomb and Johnson&Johnson - brands that customers know and trust.

Category: Monthly Disposable

$18.95

See the Price of Focus Monthly Visitint

You may also consider:

  Softcon EW 2
Softcon EW 2 offer the durability of a daily wear lens and the convenience of extended wear, allowing you to use them to best suit your personal needs.Note: Some Parameters of this lens are Made-To-Order, these parameters may have additional charges applied. ...See The Price
 
  O2 Optix
O2 Optix (commonly referred to as O2 Optics) is CIBA Vision's brand 1-2 week disposable contact lens.O2 Optix is made with a revolutionary silicone hydrogel technology allowing 5 times more oxygen to reach the eye than the leading 2-week lens to help protect you from the signs and symptoms of corneal oxygen deficiency. ...See The Price
 
  Air Optix for Astigmatism
Air Optix for Astigmatism is a two-week daily wear toric lens developed by CIBA Vision. This lens is made with a revolutionary silicone hydrogel technology allowing 5 times more oxygen to reach the eye than the leading 2-week lens to help protect you from the signs and symptoms of corneal oxygen deficiency. Air Optix for Astigmatism lenses use the revolutionary Precision Balance 8/4 Design for outstanding stable vision and all day comfort.Air Optix for Astigmatism are intended for daily or flexi ...See The Price